Duvakitug outperformed placebo at week 14 in endoscopic response and was well tolerated among patients with moderately to severely active Crohn’s disease, according to research presented at ACG Annual ...

Q3 2025 Management View CEO Gerard Michel highlighted the "compelling results from the investigator-sponsored CHOPIN trial" and announced the first patient dosed in the company's colorectal cancer ...

An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of. For patients with triple-negative breast cancer, there are now several clinical ...

Please provide your email address to receive an email when new articles are posted on . Most U.S. counties do not have any active cancer clinical trials, and more than half do not have an oncologist.

PHOENIX -- A first-in-class oral miR-124 enhancer significantly improved clinical remission and endoscopic outcomes for ...

Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ipsilateral breast ...

Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely ...